Al Hammadi Holding (4007) Fundamentals 2026 — P/E 18.9x, Revenue Analysis | SniperIQ
Al Hammadi Holding (4007) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 4.2B, trading at SAR 26.50 on the SAU. This SniperIQ fundamentals page covers Al Hammadi Holding's valuation (P/E 18.9x, P/B 2.1x), profitability (net margin 17.9%), revenue (SAR 1.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Al Hammadi Holding's market cap?
Al Hammadi Holding (4007) has a market capitalization of approximately SAR 4.2B, trading at SAR 26.50 on the SAU. Market cap moves with the live share price.
What is Al Hammadi Holding's P/E ratio?
Al Hammadi Holding's trailing twelve-month P/E ratio is 18.9x, with a price-to-book (P/B) of 2.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Al Hammadi Holding?
Al Hammadi Holding runs a net profit margin of 17.9%, a gross margin of 29.4%, and an operating margin of 15.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Al Hammadi Holding generate?
Al Hammadi Holding reported revenue of SAR 1.2B for fiscal year 2025, with net income of SAR 242M and earnings per share (EPS) of 1.51. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Al Hammadi Holding pay a dividend?
Al Hammadi Holding offers a trailing dividend yield of about 3.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Al Hammadi Holding financially healthy?
Al Hammadi Holding carries a debt-to-equity ratio of 0.14x and a current ratio of 2.35x, with a market beta of 0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Al Hammadi Holding a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Al Hammadi Holding (4007) the key facts are: market cap SAR 4.2B, P/E 18.9x, revenue SAR 1.2B, 52-week range 23.42-36.96. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Al Hammadi Holding's full fundamentals live
Get Al Hammadi Holding's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.